127 related articles for article (PubMed ID: 10849775)
1. Influence of proliferation, differentiation and dedifferentiation factors on the expression of the lysosomal cysteine proteinase cathepsin L (CL) in thyroid cancer cell lines.
Plehn A; Günther D; Aurich H; Hoang-Vu C; Weber E
Adv Exp Med Biol; 2000; 477():487-95. PubMed ID: 10849775
[No Abstract] [Full Text] [Related]
2. Expression of cathepsins B and L in human lung epithelial cells is regulated by cytokines.
Gerber A; Welte T; Ansorge S; Bühling F
Adv Exp Med Biol; 2000; 477():287-92. PubMed ID: 10849756
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer cells express cathepsins B and L but not cathepsins K or H.
Ishibashi O; Mori Y; Kurokawa T; Kumegawa M
Cancer Biochem Biophys; 1999 Jul; 17(1-2):69-78. PubMed ID: 10738903
[TBL] [Abstract][Full Text] [Related]
4. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.
Weyemi U; Caillou B; Talbot M; Ameziane-El-Hassani R; Lacroix L; Lagent-Chevallier O; Al Ghuzlan A; Roos D; Bidart JM; Virion A; Schlumberger M; Dupuy C
Endocr Relat Cancer; 2010 Mar; 17(1):27-37. PubMed ID: 19779036
[TBL] [Abstract][Full Text] [Related]
5. Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease.
Shuja S; Murnane MJ
Int J Cancer; 1996 May; 66(4):420-6. PubMed ID: 8635854
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester stimulated cathepsin L expression in U937 cells.
Atkins KB; Troen BR
Cell Growth Differ; 1995 Jun; 6(6):713-8. PubMed ID: 7669726
[TBL] [Abstract][Full Text] [Related]
7. Nuclear cysteine cathepsin variants in thyroid carcinoma cells.
Tedelind S; Poliakova K; Valeta A; Hunegnaw R; Yemanaberhan EL; Heldin NE; Kurebayashi J; Weber E; Kopitar-Jerala N; Turk B; Bogyo M; Brix K
Biol Chem; 2010 Aug; 391(8):923-35. PubMed ID: 20536394
[TBL] [Abstract][Full Text] [Related]
8. Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.
Maciewicz RA; Wardale RJ; Etherington DJ; Paraskeva C
Int J Cancer; 1989 Mar; 43(3):478-86. PubMed ID: 2647640
[TBL] [Abstract][Full Text] [Related]
9. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages.
Lah TT; Hawley M; Rock KL; Goldberg AL
FEBS Lett; 1995 Apr; 363(1-2):85-9. PubMed ID: 7729559
[TBL] [Abstract][Full Text] [Related]
10. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells.
Korem S; Resnick MB; Kraiem Z
J Clin Endocrinol Metab; 1999 Sep; 84(9):3322-7. PubMed ID: 10487706
[TBL] [Abstract][Full Text] [Related]
11. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
[TBL] [Abstract][Full Text] [Related]
12. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
[TBL] [Abstract][Full Text] [Related]
13. [Changes in active cysteine cathepsins in lysosomes from tissues thyroid papillary carcinomas with various biological characteristics].
Kalinichenko OV; Myshunina TM; Tron'ko MD
Fiziol Zh (1994); 2013; 59(5):11-9. PubMed ID: 24400560
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression.
Macabeo-Ong M; Shiboski CH; Silverman S; Ginzinger DG; Dekker N; Wong DT; Jordan RC
Oral Oncol; 2003 Oct; 39(7):638-47. PubMed ID: 12907202
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal acid hydrolases of the cathepsin family are novel targets of INSL3 in human thyroid carcinoma cells.
Bialek J; Hombach-Klonisch S; Fiebig B; Weber E; Hoang-Vu C; Klonisch T
Ann N Y Acad Sci; 2009 Apr; 1160():361-6. PubMed ID: 19416220
[TBL] [Abstract][Full Text] [Related]
16. Cysteine proteinases in GH4C1 cells, a rat pituitary tumor cell line, are secreted by the constitutive and regulated secretory pathways.
Waguri S; Sato N; Watanabe T; Ishidoh K; Kominami E; Sato K; Uchiyama Y
Eur J Cell Biol; 1995 Aug; 67(4):308-18. PubMed ID: 8521870
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein production in human follicular thyroid carcinoma cells.
Bachrach LK; Nänto-Salonen K; Tapanainen P; Rosenfeld RG; Gargosky SE
Growth Regul; 1995 Jun; 5(2):109-18. PubMed ID: 7542953
[TBL] [Abstract][Full Text] [Related]
18. Evidence that aspartic proteinase is involved in the proteolytic processing event of procathepsin L in lysosomes.
Nishimura Y; Kawabata T; Furuno K; Kato K
Arch Biochem Biophys; 1989 Jun; 271(2):400-6. PubMed ID: 2658811
[TBL] [Abstract][Full Text] [Related]
19. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
Colella R; Goodwyn E; Gopal P
Cancer Lett; 2002 Nov; 185(2):163-72. PubMed ID: 12169390
[TBL] [Abstract][Full Text] [Related]
20. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line.
De Stefanis D; Démoz M; Dragonetti A; Houri JJ; Ogier-Denis E; Codogno P; Baccino FM; Isidoro C
Cell Tissue Res; 1997 Jul; 289(1):109-17. PubMed ID: 9182605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
